This funding opportunity supports innovative basic research projects investigating the biological and genetic bases of cancer health disparities. It encourages mechanistic studies, development and testing of new methodologies and models, and secondary data analyses. The grant also aims to build a nationwide cohort of scientists with expertise in cancer health disparities to expand research resources such as biospecimens and patient-derived models. Clinical trials are not allowed under this R21 mechanism.
Eligible applicants include a wide range of organizations such as for-profit entities (excluding small businesses), small businesses, various government entities, nonprofits with or without 501(c)(3) status, and institutions of higher education. Specific eligibility details are provided in the full
